Clinical trial
Clinical Trial on the Effects of Long Term Administration of 20% Albumin in the Cardiovascular and Renal Function, And Hepatic Hemodynamics in Advanced Patients With Cirrhosis and Ascites.
NCT00968695 is registered in ClinicalTrials.gov with Instituto Grifols, S.A. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Clinical Trial on the Effects of Long Term Administration of 20% Albumin in the Cardiovascular and Renal Function, And Hepatic Hemodynamics in Advanced Patients With Cirrhosis and Ascites.
- Lead sponsor
- Instituto Grifols, S.A.
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- July 31, 2009
- Completion date
- April 30, 2014
- Enrollment
- 33 (actual)
- Sites
- 6
Conditions
As the registry lists them; a condition with its own page is linked.
ascites, cirrhosis